Biotech Stock Ideas

For the Curious Investor.

I read 100+ announcements every week.
You get the 5-minute insights every day.

100% Free. Unsubscribe anytime.

The Armchair Stock Picks

My Third Armchair Pick: Control Bionics (ASX: CBL)

Jun 25, 2026

•

13 min read

My Second Armchair Pick: Emyria (ASX: EMD)

Apr 20, 2026

•

11 min read

My First Armchair Pick: Tetratherix (ASX: TTX)

Mar 16, 2026

•

24 min read

Stock Features

Margin Call: The Optiscan Story (ASX: OIL)

Jul 2, 2026

•

12 min read

A Deep Dive into Brain-Computer Interfaces: The US$400 Billion Industry

Jul 1, 2026

•

7 min read

A Closer Look at the ASX Supervision Report

Jun 30, 2026

•

6 min read

Acid Test: Definium’s Positive Phase 3 LSD Readout

Jun 29, 2026

•

4 min read

Is Medtech Back?

Jun 26, 2026

•

3 min read

My Third Armchair Pick: Control Bionics (ASX: CBL)

Jun 25, 2026

•

13 min read

Avecho’s (AVE) Phase 3 Insomnia Result Awakens Biotech Market

Jun 24, 2026

•

4 min read

Fighting over the shrinking pie

Jun 23, 2026

•

9 min read

No Pain, No Gain: The Paradigm Story (ASX: PAR)

Jun 22, 2026

•

9 min read

Tax On, Tax Off: What new changes mean for biotech

Jun 19, 2026

•

4 min read

Catalyst Munting: Cynata (CYP) Trial Pulls up Short

Jun 18, 2026

•

4 min read

Fireside Conversation with Emyria

Jun 17, 2026

•

4 min read

...

Biotech Stock Ideas

For the Curious Investor.

The Armchair Stock Picks

My Third Armchair Pick: Control Bionics (ASX: CBL)

My Second Armchair Pick: Emyria (ASX: EMD)

My First Armchair Pick: Tetratherix (ASX: TTX)

Stock Features

Margin Call: The Optiscan Story (ASX: OIL)

A Deep Dive into Brain-Computer Interfaces: The US$400 Billion Industry

A Closer Look at the ASX Supervision Report

Acid Test: Definium’s Positive Phase 3 LSD Readout

Is Medtech Back?

My Third Armchair Pick: Control Bionics (ASX: CBL)

Avecho’s (AVE) Phase 3 Insomnia Result Awakens Biotech Market

Fighting over the shrinking pie

No Pain, No Gain: The Paradigm Story (ASX: PAR)

Tax On, Tax Off: What new changes mean for biotech

Catalyst Munting: Cynata (CYP) Trial Pulls up Short

Fireside Conversation with Emyria

The Armchair Analyst